STOCK TITAN
  1. Home
  2. News
  3. GEHC

GE HealthCare Technologies Inc. - GEHC STOCK NEWS

Welcome to our dedicated page for GE HealthCare Technologies news (Ticker: GEHC), a resource for investors and traders seeking the latest updates and insights on GE HealthCare Technologies stock.

GE HealthCare Technologies Inc. (NYSE: GEHC) is a leading global innovator in medical technology, pharmaceutical diagnostics, and digital solutions. The company operates through four main segments: Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Of these, the Imaging segment generates the majority of the company’s revenue.

GE HealthCare is dedicated to providing transformational medical technologies and services that enhance access to quality, affordable healthcare worldwide. Through its cutting-edge products and comprehensive solutions, the company aims to improve patient outcomes and streamline healthcare delivery.

Recent achievements include advancements in artificial intelligence (AI) integration within medical imaging, which supports more accurate and efficient diagnostics. The company is also involved in numerous partnerships with healthcare providers and research institutions to drive innovation and improve global healthcare standards.

Financially, GE HealthCare has showcased robust performance, with steady revenue growth and strong market presence. The company continuously invests in R&D to maintain its edge in the competitive healthcare industry. Their suite of products includes advanced imaging machines, ultrasound devices, patient monitoring systems, and contrast media for diagnostic imaging.

As part of a highly regulated industry, GE HealthCare adheres to strict compliance standards and maintains rigorous quality controls across its operations. The company actively engages with its community, although it reserves the right to monitor and manage public interactions to uphold professional and constructive discourse.

News

GE HealthCare Announces New Innovations and Collaborations in Image Guided Therapy as part of TCT2023 Cardiology Care Pathway Showcase

Rhea-AI Summary
GE HealthCare will showcase new technologies in interventional cardiology at the 2023 Transcatheter Cardiovascular Therapeutics conference. The innovations include the Allia IGS Pulse image-guided system, INTERACT Touch for multi-modality integration, and the 3D Stent for augmented imaging. The company aims to optimize workflows, increase collaboration, and drive better patient outcomes in the treatment of cardiovascular disease.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.09%
Tags
none
-
News

GE HealthCare and Novo Nordisk to Collaborate to Advance Novel Non-Invasive Treatment for Type 2 Diabetes and Obesity with Ultrasound

Rhea-AI Summary
GE HealthCare collaborates with Novo Nordisk to develop peripheral focused ultrasound therapy for chronic disease management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.34%
Tags
none
-
News

GE HealthCare to Announce Third Quarter 2023 Results on October 31, 2023

Rhea-AI Summary
GE HealthCare to announce Q3 2023 financial results
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.12%
Tags
earnings
News

GE HealthCare Receives FDA Clearance of Allia IGS Pulse - the Next Generation of Image-Guided Systems Designed for Cardiac Imaging Excellence

Rhea-AI Summary
GE HealthCare announces FDA clearance of Allia IGS Pulse, a new image guided system for cardiovascular diseases in interventional cardiology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.36%
Tags
clinical trial
-
News

GE HealthCare Announces Study Results Demonstrating Portrait Mobile Continuous Monitoring Solution Performance with Patients and Care Teams in the Ward

Rhea-AI Summary
Continuous monitoring of vital signs with GE HealthCare's Portrait Mobile can optimize system configuration and mitigate alarm fatigue in the ward environment, according to a pilot study presented at the ASA Annual Meeting.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.36%
Tags
none
-
News

GE HealthCare Signs $44 Million Contract with BARDA to Develop Artificial Intelligence-Augmented Ultrasound Technology to Aid Clinicians in Diagnosing and Treating Traumatic Injury and Enhance National Preparedness for Mass Casualty Incidents

Rhea-AI Summary
GE HealthCare signs $44 million contract with BARDA to develop advanced ultrasound technology with AI applications for diagnosing lung pathology and traumatic injury.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.87%
Tags
none
News

SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers

Rhea-AI Summary
GE HealthCare signs global licensing agreement with SOFIE Biosciences for development and commercialization of radiopharmaceutical diagnostics
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.6%
Tags
none
-
News

GE HealthCare’s growing list of medical institutions conducting human subject research studies with its novel photon counting CTi technology further expands with the addition of Stanford Medicine

Rhea-AI Summary
GE HealthCare collaborates with Stanford Medicine to advance photon counting CT technology
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.96%
Tags
none
-
News

GE HealthCare Launches Enhanced Venue Family Point-of-Care Ultrasound Systems Featuring AI-Driven Caption Guidance

Rhea-AI Summary
GE HealthCare integrates Caption Guidance AI-driven technology into Venue Family ultrasound systems to provide real-time guidance for capturing diagnostic-quality cardiac images.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.27%
Tags
AI
News

GE HealthCare and University Hospitals Enter 10-Year Strategic Collaboration to Contemporize Its Imaging Fleet and Implement Enterprise Digital Solutions to Help Improve Patient Care and Optimize Processes

Rhea-AI Summary
GE HealthCare and University Hospitals announce a 10-year strategic collaboration to bring GE HealthCare technologies to UH across its radiology practice and UH Harrington Heart & Vascular Institute, providing contemporary equipment and digital solutions to improve processes for the benefit of patients and clinicians.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.41%
Tags
none

FAQ

What is the current stock price of GE HealthCare Technologies (GEHC)?

The current stock price of GE HealthCare Technologies (GEHC) is $86.93 as of February 4, 2025.

What is the market cap of GE HealthCare Technologies (GEHC)?

The market cap of GE HealthCare Technologies (GEHC) is approximately 40.1B.

What does GE HealthCare Technologies Inc. do?

GE HealthCare Technologies Inc. provides transformative medical technologies, pharmaceutical diagnostics, and digital solutions to improve healthcare access and quality globally.

What are the main business segments of GE HealthCare?

The main business segments are Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx).

How does GE HealthCare generate most of its revenue?

The company generates the majority of its revenue from the Imaging segment.

What recent advancements has GE HealthCare made?

GE HealthCare has made significant advancements in AI integration within medical imaging, improving diagnostic accuracy and efficiency.

Who are GE HealthCare's partners?

The company collaborates with healthcare providers and research institutions to drive innovation and improve healthcare standards.

How does GE HealthCare ensure compliance?

GE HealthCare adheres to strict regulatory compliance standards and maintains rigorous quality controls across its operations.

What products does GE HealthCare offer?

GE HealthCare offers a range of products, including imaging machines, ultrasound devices, patient monitoring systems, and diagnostic contrast media.

What is GE HealthCare's commitment to the community?

The company engages actively with its community and strives to maintain professional and positive interactions while monitoring public posts and conversations.

How has GE HealthCare performed financially?

GE HealthCare has shown robust financial performance with steady revenue growth, supported by continuous investment in research and development.

What is GE HealthCare's mission?

GE HealthCare is committed to improving patient outcomes and making quality healthcare more accessible and affordable worldwide.
Stock GEHC logo
GE HealthCare Technologies Inc.

Nasdaq:GEHC

GEHC Rankings

#337 Ranked by Market Cap
#2121 Ranked by Dividends

GEHC Stock Data

40.07B
442.77M
3.09%
84.02%
2.79%
Health Information Services
X-ray Apparatus & Tubes & Related Irradiation Apparatus
Link
United States of America
CHICAGO